XtalPi Holdings Ltd 2024 AR2
The report highlights XtalPi Holdings Limited's first annual results and ESG report since its listing on the Hong Kong Stock Exchange in 2024. The company achieved a 52.8% increase in revenue to RMB 266.4 million and successfully narrowed its adjusted net loss. Key achievements include the launch of the next-generation drug crystallization platform Xtalgazer and the development of the PatSight patent data mining platform. On the ESG front, the company established a formal ESG governance structure, obtained ISO 14001 and ISO 45001 certifications, and reduced its water consumption by 37% compared to 2023.
Company: XtalPi Holdings Ltd
Sector: Health Care
Country: China
Year: 2024
Type: AR2
Pages: 222
XtalPi Holdings Ltd
Annual Report
The report highlights XtalPi Holdings Limited's first annual results and ESG report since its listing on the Hong Kong Stock Exchange in 2024. The company achieved a 52.8% increase in revenue to RMB 266.4 million and successfully narrowed its adjusted net loss. Key achievements include the launch of the next-generation drug crystallization platform Xtalgazer and the development of the PatSight patent data mining platform. On the ESG front, the company established a formal ESG governance structure, obtained ISO 14001 and ISO 45001 certifications, and reduced its water consumption by 37% compared to 2023.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees